Respiratory Care Devices Market Overview, 2023-28

The global burden of respiratory diseases represents a significant and ever-growing public health challenge, with far-reaching implications for individuals, communities, and healthcare systems worldwide. Respiratory diseases encompass a wide spectrum of conditions, including chronic obstructive pulmonary disease (COPD), asthma, lung infections, interstitial lung diseases, and more. These disorders collectively exert a substantial toll on human health, quality of life, and economic resources. The global burden of respiratory diseases extends beyond individual suffering to encompass economic consequences as well. Healthcare expenditures related to these conditions, including hospitalizations, medications, and rehabilitation, represent a substantial portion of healthcare budgets in many countries. Efforts to mitigate the global burden of respiratory diseases are multifaceted. Innovations in respiratory care devices have significantly improved the quality of life for individuals with respiratory conditions and have enhanced the efficiency and effectiveness of healthcare delivery. These innovations span various aspects of respiratory care, from diagnosis to treatment and long-term management ISO 18562 is a series of standards that outlines the general principles for the evaluation of breathing gas pathways of medical devices used in respiratory care or to supply anesthesia or other substances through the respiratory tract. The key trends for the increased market of respiratory care devices includes the rising med-tech research and development expenditure, accelerating smart inhaler industry, technological advancements in ventilators, increasing use of AI to develop respiratory devices to treat Asthma and COPD, Increasing presence in home care settings, and Growth from product innovations.

According to the research report, “Global Respiratory Care Devices Market Overview, 2028” the market is anticipated to cross USD 35 Billion by 2028, increasing from USD 22.94 Billion in 2022. The market is expected to grow with 7.86% CAGR by 2023-28. The global respiratory care devices market is experiencing significant expansion as a result of several key factors. One of the primary drivers is the increasing prevalence of respiratory diseases. As the conditions become more prevalent, the demand for respiratory care devices, including ventilators, nebulizers, CPAP/BiPAP machines, and oxygen therapy equipment, continues to grow. Moreover, technological advancements and innovations have played a pivotal role in the market's expansion. Smart inhalers, telemedicine integration, and remote monitoring capabilities have revolutionized the way respiratory conditions are managed, making treatments more efficient and personalized. These technologies not only enhance patient compliance but also reduce the burden on healthcare systems by offering remote care options. The COVID-19 pandemic has underscored the importance of respiratory care devices, leading to increased investment in research and development in this sector. Ventilators and pulse oximeters, for example, gained significant attention during the pandemic due to their critical roles in treating severe cases and monitoring patients' oxygen levels. The global expansion of the respiratory care devices market is also driven by the growing awareness of the importance of early diagnosis and proactive management of respiratory conditions, which has led to increased screening, early intervention, and adoption of home-based care solutions. This shift towards preventive care not only benefits patients but also helps reduce the strain on healthcare facilities, particularly in light of rising healthcare costs.

Based on the geography, the market is segmented into regions including North America, Europe, Asia Pacific, South America, and Middle East & Africa. The market for respiratory care equipment is now dominated by North America, which is followed closely by Europe, the Asia-Pacific region, South America, the Middle East, and Africa. This regional hierarchy takes into account the developed healthcare systems and high level of awareness of respiratory health issues in North America and Europe, as well as the presence of significant market participants and investments in R&D. Due to its expanding population, rising healthcare spending, and rising prevalence of respiratory diseases, the Asia-Pacific region is quickly becoming a significant market. Meanwhile, South America, the Middle East, and Africa are also experiencing steady growth as a result of better healthcare access and a growing focus on respiratory care. This worldwide distribution highlights the ubiquity of respiratory conditions and the increasing recognition of the importance of effective respiratory care across diverse regions. The market's ongoing expansion in these areas signifies a commitment to addressing respiratory health on a global scale, driven by advancements in technology, increased awareness, and a shared goal of enhancing patient well-being.

Therapeutic devices, monitoring devices, diagnostic devices, and consumables and accessories make up the four product-based market segments. The therapeutic device segment did indeed dominate the global market for respiratory care equipment. A variety of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and others, require the use of respiratory care devices. Due to the frequency of respiratory ailments, therapeutic devices play a significant part in treating respiratory conditions and are frequently in great demand. Inhalers, ventilators, Positive Airways Pressure (PAP) equipment, humidifiers, nebulizers, and other products (oxygen concentrators, oxygen hoods), are some of the popular therapeutic equipment on the market. The report is divided into monitoring equipment, such as gas analyzers and pulse oximeters. Over the years, a number of factors have contributed to the tremendous growth and diversity of the global pulse oximeter and gas analyzer market. Particularly in light of the COVID-19 epidemic, pulse oximeters, which are primarily used to detect oxygen saturation levels in the blood, have become extremely popular since they provide a quick and painless way to keep track on respiratory health. The utility of both pulse oximeters and gas analyzers has been improved by technological developments, such as the incorporation of wireless connectivity and data management systems, which has contributed to their widespread adoption in healthcare facilities, laboratories, industrial settings, and even among consumers.

Based on the consumables and accessories of respiratory care devices, the market is further distinguished into Disposable Resuscitators, Breathing Circuits, Masks, Tracheostomy Tubes, and Others (Nasal Cannulas). In the global market for medical equipment, disposable resuscitators did hold a considerable market share. In emergency medical care, disposable resuscitators, also known as bag-valve masks, are essential, especially in instances where immediate ventilation support is needed, such as cardiac arrests, trauma cases, or respiratory distress conditions. There are a number of important variables that contribute to their market domination. Based on the diagnostics devices, the market is categorized into Spirometers, Polysomnography Devices, and Peak Flow meters. Spirometers are vital diagnostic tools used to measure lung function and airflow, making them essential for assessing various respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung diseases.

According to the market segmentation based on end-users, which includes hospitals, ambulatory care centers (ACCs), home care settings, and other end-users, the global market for respiratory care equipment is diverse and dynamic. Hospitals undoubtedly hold the biggest market share among these sectors, partly because of the extensive use of respiratory care devices in inpatient settings. Hospitals serve as the forefront of healthcare, providing care for a range of respiratory conditions as well as treating acute exacerbations of chronic illnesses like COPD and the urgent needs of patients in emergency departments. Respiratory care devices are widely used because of the crucial role they play in these high-acuity scenarios, where rapid and accurate action might mean the difference between life and death. Ambulatory care centers (ACCs), which serve as outpatient care providers, come in second in terms of market share. ACCs are equipped with respiratory care equipment to better handle patients with a variety of respiratory disorders than traditional hospitals are. The management of chronic diseases requires the use of these facilities, which also do routine check-ups and treatments. Respiratory care equipment is widely used to monitor and help patients with conditions like asthma, bronchitis, and sleep apnea. Another large market sector is the home care settings. The trend toward providing healthcare at home has increased the usage of respiratory support equipment in a familiar and comfortable setting. Devices including oxygen concentrators, nebulizers, and CPAP machines help patients with chronic respiratory disorders manage their conditions easily while maintaining a higher quality of life. Other healthcare facilities and providers, such as long-term care facilities, rehabilitation centers, and specialist clinics, are included in the "Other End User" category. Although to a relatively lower level, these environments also contribute to the demand for respiratory care devices.

Recent Developments

• Trilogy Evo ventilator, launched in 2021 by Philips Healthcare, this device is designed for patients with acute and chronic respiratory failure. It has advanced ventilation modes, enhanced monitoring capabilities, and remote connectivity.
• Spirofy, launched in India by Cipla, this portable, wireless device can conduct lung function tests outdoors and in distant locations. It's designed to better diagnose patients with COPD (chronic obstructive pulmonary disease) and asthma.
• In 2023, Vitalograph launched the VitaloPFT series at the Arab Health Exhibition. The VitaloPFT series was introduced to supply partners and healthcare professionals from all over the world. The series is being released globally in phases.

Competitive Landscape:

Koninklijke Philips N.V., Medtronic Inc, Masimo Corporation, Cardinal Health, Inc, Medline Industries, Baxter International Inc., Stryker Corporation, Siemens AG , GE HealthCare Technologies, Inc., Teleflex Incorporated, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited , Vapotherm Inc., Getinge AB, Dragerwerk AG & Co. KGaA, Invacare Corporation, Nidek Medical products Inc. , Precision Medical Inc, Teijin Pharma Limited, Besco Medical Limited

Market Drivers:

Shift Towards Home-Based Care: Patients are increasingly favoring the convenience and comfort of managing their respiratory conditions within the familiar setting of their homes. This transition is facilitated by the development of user-friendly, portable, and remote monitoring respiratory care devices. By offering patients the ability to self-manage their conditions in a home environment, this trend not only enhances their quality of life but also aligns with the broader movement towards value-based care. Home-based care is often more cost-effective for healthcare systems, reduces the burden on healthcare facilities, and allows patients to lead more independent lives. This shift towards home-based care is driving innovation in the design and functionality of respiratory care devices, focusing on portability, ease of use, and remote monitoring capabilities to empower patients in taking charge of their respiratory health.

Technological Advancements: Technological advancements stand as a prominent and transformative market driver within the global respiratory care devices sector. The continuous evolution of technology has led to the development of increasingly sophisticated and user-friendly devices, redefining the landscape of respiratory care. Innovations in this field have given rise to portable ventilators that offer greater patient mobility and smart inhalers equipped with precise dosing and monitoring capabilities. These advancements not only enhance patient comfort but also elevate the quality of care delivered by healthcare professionals. Patients benefit from improved treatment experiences, while healthcare providers can offer more precise and patient-centered care. Additionally, technology has facilitated the integration of digital health solutions, such as telehealth services and remote monitoring, providing patients with more accessible and efficient respiratory care options. The ongoing technological revolution within the respiratory care devices market promises to continue shaping the industry and driving greater adoption of cutting-edge solutions that ultimately enhance patient outcomes and improve the overall quality of respiratory care.

Market Trends

Digital Health Integration: This trend reflects the growing integration of digital health technologies into the field of respiratory care. Respiratory care devices are increasingly becoming interconnected with telehealth solutions, remote monitoring devices, and mobile applications designed to empower patients in tracking and managing their respiratory health. This integration not only enhances patient compliance with treatment plans but also allows for timely and informed interventions by healthcare providers. The real-time data and insights provided by these digital solutions enable more personalized and patient-centric care, ultimately improving the overall management of respiratory conditions. As a result, healthcare professionals can monitor patients more effectively, identify potential issues in advance, and make data-driven decisions, all of which contribute to better patient outcomes. Digital Health Integration not only enhances the quality of care but also aligns with the broader trend of digitization and innovation in healthcare, marking a significant step forward in respiratory care management.

Wearable and Portable Devices: Patients and healthcare providers alike are seeking more convenient and flexible solutions for managing respiratory conditions. Wearable respiratory devices, such as compact oxygen concentrators and smart inhalers, empower patients with greater mobility and control over their health management. These devices are designed to be lightweight, easy to carry, and user-friendly, making them suitable for use at home or on the go. For patients, this trend represents a significant improvement in their quality of life, as it allows them to maintain their respiratory care routines without being tethered to a specific location. Healthcare providers benefit from the ability to monitor patient progress remotely, promoting timely interventions and personalized care.

Market Challenges:

Patient Compliance: Patients with respiratory conditions often require a regimen of therapies and medications to manage their health effectively. However, achieving and maintaining patient compliance can be a complex and persistent challenge. Patients may struggle with adherence for various reasons, including discomfort associated with certain devices, the potential for side effects from medications, or a lack of understanding about the importance of following treatment plans consistently. This challenge is further exacerbated in chronic respiratory conditions where ongoing management is essential. Overcoming the issue of patient compliance requires a multifaceted approach, including patient education, support, and the development of more user-friendly and patient-centric respiratory care devices.

Regulatory Hurdles: Regulatory hurdles pose a significant challenge in the global respiratory care devices market. The development, manufacturing, and marketing of these medical devices are subject to stringent regulatory requirements and compliance standards imposed by health authorities and government agencies. Navigating these complex regulatory landscapes can be a time-consuming and resource-intensive process for manufacturers. Ensuring that respiratory care devices meet the highest safety and quality standards while adhering to the evolving regulatory framework is paramount. Non-compliance or delays in meeting these requirements can impede product development and market entry, impacting the industry's ability to bring innovative solutions to patients in a timely manner.

Covid Impact:

The COVID-19 pandemic has had a profound impact on the global respiratory care devices market. With the surge in COVID-19 cases, there was an unprecedented demand for respiratory care equipment and services, particularly ventilators and oxygen therapy devices, to treat severe cases of the virus. This surge in demand strained supply chains and led to shortages in critical equipment in many regions. Healthcare facilities worldwide faced significant challenges in accommodating the influx of patients requiring advanced respiratory interventions. The pandemic also prompted a rapid shift towards telehealth services, including remote monitoring of respiratory conditions, as healthcare providers sought to reduce in-person medical visits and minimize the risk of virus transmission. The COVID-19 pandemic highlighted the critical importance of respiratory care and underscored the need for preparedness and investment in this sector. It accelerated the adoption of telehealth and digital solutions for remote monitoring of respiratory conditions, pushing the industry towards greater innovation and the development of more accessible and efficient respiratory care devices.

Considered in this report:

• Geography: Global
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Global Respiratory care devices market Outlook with its value and forecast along with its segments
• Region & Country-wise Respiratory care devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions & Countries covered in the report

• North America (United States, Canada, Mexico)
• Europe (Germany, United Kingdom, France, Spain, Italy, Russia)
• Asia-Pacific (China, Japan, India, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle-East & Africa (UAE, Saudi Arabia, South Africa

By Product Type:

• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:

• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:

• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.